Concepedia

Nicholas Clarke

NC

Statistics

Publications

7

Citations

278

H-Index

7

Active since

1993

Affiliations

Pfizer (United Kingdom)(Current)

Pfizer (United States)

Nicholas Clarke is an author at Pfizer (United Kingdom) specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

1993–2018

7

Publications

7

Inhalation by Design: Novel Ultra-Long-Acting β<sub>2</sub>-Adrenoreceptor Agonists for Inhaled Once-Daily Treatment of Asthma and Chronic Obstructive Pulmonary Disease That Utilize a Sulfonamide Agonist Headgroup

Paul A. Glossop, Charlotte A. L. Lane, David Price et al. · Journal of Medicinal Chemistry · 2010 · 74 citations · Full text

, , +20

Pharmacological activity of VUF 9153, an isothiourea histamine H3 receptor antagonist

Julie C. Barnes, Jason Brown, Nicholas Clarke et al. · European Journal of Pharmacology · 1993 · 45 citations

, , +7

Challenges of drug discovery in novel target space. The discovery and evaluation of PF-3893787: A novel histamine H4 receptor antagonist

Charles E. Mowbray, Andrew Bell, Nicholas Clarke et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 37 citations · Full text

, , +6

Preclinical Evaluation of an Inhibitor of Cytosolic Phospholipase A2α for the Treatment of Asthma

Christopher A. Hewson, Sheena Patel, Luigino Calzetta et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 35 citations

Inhalation by Design: Novel Tertiary Amine Muscarinic M<sub>3</sub>Receptor Antagonists with Slow Off-Rate Binding Kinetics for Inhaled Once-Daily Treatment of Chronic Obstructive Pulmonary Disease

Paul A. Glossop, Christine Watson, David Price et al. · Journal of Medicinal Chemistry · 2011 · 33 citations · Full text

1–5 of 7